LearnGlossaryMarketStocksSuperinvestorsSign in

CAMP

CAMP4 Therapeutics Corporation

Healthcare · $249M market cap

Verdict

We can't put a fair value on CAMP right now. It looks like a preferred share, note or other security rather than ordinary common stock. The figures we receive belong to the parent company, so they can't value this security.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth—?
Sales growth3.2% a year✗
Free cash flow growth11.9% a year✓
Return on invested capital-50.1%✗

Follow CAMP

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Aug 31, 2026: 1 open-market purchase worth $40K. Why purchases matter

Purchases

Gold Kelly

Chief Financial Officer · 2026-08-31

Bought

$40K

About CAMP4 Therapeutics Corporation

CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.

Biotechnology

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works